Australia's largest stock trading and investment forum Australia's #1 stock forum

LNK

Click for more information

0.00%

$2.09 link administration holdings limited

Ann: Update on PES and PEXA, page-39

First 39 Last

Share
Profile

Follow
Cryptonium

157 Posts.

5

05/02/21

12:24

Post #: 50736642
Share

Originally posted by Tassie3207: ↑

As a long term holder of LNK, I still cannot get any sensible answers as to why it make strategic sense to sell the jewell in the crown. Appears to me that the only reason the board is selling PEXA is to make the company less appealing as a take over target, how is that in the interest of share holders. As correctly pointed out by many before me they cannot IPO PEXA without all other share holders agreeing to sell, which they appear to be unwilling to do as they see better value in keeping it, Therefore the only we we will get exposure to this great asset is be retaining it.

Expand

Their CEO stated exactly why. To streamline their core business and reduce their huge debt on top of freeing capital for further projects. The sooner the PEXA bulls are gone from the registry, the better.

LNK Price at posting: $4.90 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 39 Last

Add LNK (ASX) to my watchlist

SPONSORED BY